Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily-Reference-Cited by-同舟云学术

Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily

Published:2010-04 Issue:4 Volume:32 Page:678-690
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Haag Sebastian,Holtmann Gerald

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. The Montreal definition and classification of gastroesophageal reflux disease: A global evidencebased consensus;Vakil;Am J Gastroenterol,2006

2. Global clinical symptom spectrum in gastroesophageal reflux disease;Mönnikes;J Clin Gastroenterol,2007

3. Novel measurement of rapid treatment success with ReQuest: First and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole;Mönnikes;Digestion,2007

4. Medical treatments in the short term management of reflux oesophagitis;Khan;Cochrane Database Syst Rev,2007

5. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study;Miner;Am J Gastroenterol,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of sex on the association between body mass index and frequency of upper gastrointestinal symptoms;JGH Open;2020-06-05

2. Salivary stimulation-could it play a role in GERD management?;Journal of Otolaryngology-ENT Research;2018-05-02

3. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus;Drugs;2017-02-23

4. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015;Journal of Gastroenterology;2016-06-21

5. Multi-indication Pharmacotherapeutic Multicriteria Decision Analytic Model for the Comparative Formulary Inclusion of Proton Pump Inhibitors in Qatar;Clinical Therapeutics;2016-05